109 related articles for article (PubMed ID: 18785201)
21. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility.
McGrath M; Hankinson SE; Arbeitman L; Colditz GA; Hunter DJ; De Vivo I
Carcinogenesis; 2004 Apr; 25(4):559-65. PubMed ID: 14656940
[TBL] [Abstract][Full Text] [Related]
22. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
23. Genetic predisposition, parity, age at first childbirth and risk for breast cancer.
Butt S; Harlid S; Borgquist S; Ivarsson M; Landberg G; Dillner J; Carlson J; Manjer J
BMC Res Notes; 2012 Aug; 5():414. PubMed ID: 22867275
[TBL] [Abstract][Full Text] [Related]
24. CYP19 (aromatase) haplotypes and endometrial cancer risk.
Paynter RA; Hankinson SE; Colditz GA; Kraft P; Hunter DJ; De Vivo I
Int J Cancer; 2005 Aug; 116(2):267-74. PubMed ID: 15800924
[TBL] [Abstract][Full Text] [Related]
25. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Tinholt M; Viken MK; Dahm AE; Vollan HK; Sahlberg KK; Garred O; Børresen-Dale AL; Jacobsen AF; Kristensen V; Bukholm I; Kåresen R; Schlichting E; Skretting G; Lie BA; Sandset PM; Iversen N
BMC Cancer; 2014 Nov; 14():845. PubMed ID: 25407022
[TBL] [Abstract][Full Text] [Related]
26. An investigation of the effects of FGFR2 and B7-H4 polymorphisms in breast cancer.
Ozgöz A; Samli H; Oztürk KH; Orhan B; Icduygu FM; Aktepe F; Imirzalioglu N
J Cancer Res Ther; 2013; 9(3):370-5. PubMed ID: 24125968
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
28. Dietary folate intake, MTHFR genetic polymorphisms, and the risk of endometrial cancer among Chinese women.
Xu WH; Shrubsole MJ; Xiang YB; Cai Q; Zhao GM; Ruan ZX; Cheng JR; Zheng W; Shu XO
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):281-7. PubMed ID: 17301261
[TBL] [Abstract][Full Text] [Related]
29. Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women.
Murillo-Zamora E; Moreno-Macías H; Ziv E; Romieu I; Lazcano-Ponce E; Angeles-Llerenas A; Pérez-Rodríguez E; Vidal-Millán S; Fejerman L; Torres-Mejía G
Arch Med Res; 2013 Aug; 44(6):459-66. PubMed ID: 24054997
[TBL] [Abstract][Full Text] [Related]
30. HNF1B and endometrial cancer risk: results from the PAGE study.
Setiawan VW; Haessler J; Schumacher F; Cote ML; Deelman E; Fesinmeyer MD; Henderson BE; Jackson RD; Vöckler JS; Wilkens LR; Yasmeen S; Haiman CA; Peters U; Le Marchand L; Kooperberg C
PLoS One; 2012; 7(1):e30390. PubMed ID: 22299039
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk.
Han J; Hankinson SE; De Vivo I
Carcinogenesis; 2006 Nov; 27(11):2281-5. PubMed ID: 16777993
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms and breast cancer risk: evidence from meta-analyses, pooled analyses, and genome-wide association studies.
Peng S; Lü B; Ruan W; Zhu Y; Sheng H; Lai M
Breast Cancer Res Treat; 2011 Jun; 127(2):309-24. PubMed ID: 21445572
[TBL] [Abstract][Full Text] [Related]
34. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
35. Lymphotoxin-alpha polymorphisms and the risk of endometrial cancer in Japanese subjects.
Niwa Y; Ito H; Matsuo K; Hirose K; Ito N; Mizuno M; Hamajima N; Tajima K; Nakanishi T
Gynecol Oncol; 2007 Mar; 104(3):586-90. PubMed ID: 17045328
[TBL] [Abstract][Full Text] [Related]
36. Analysis of functional germline variants in APOBEC3 and driver genes on breast cancer risk in Moroccan study population.
Marouf C; Göhler S; Filho MI; Hajji O; Hemminki K; Nadifi S; Försti A
BMC Cancer; 2016 Feb; 16():165. PubMed ID: 26920143
[TBL] [Abstract][Full Text] [Related]
37. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer.
Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP
Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969
[TBL] [Abstract][Full Text] [Related]
38. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.
Lu PH; Yang J; Li C; Wei MX; Shen W; Shi LP; Jiang ZY; Zhou N; Tao GQ
Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358
[TBL] [Abstract][Full Text] [Related]
39. Genetic variation in the androgen receptor gene and endometrial cancer risk.
Yang HP; Garcia-Closas M; Lacey JV; Brinton LA; Lissowska J; Peplonska B; Chanock S; Gaudet MM
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):585-9. PubMed ID: 19190146
[TBL] [Abstract][Full Text] [Related]
40. FGFR2 intronic SNPs and breast cancer risk: associations with tumor characteristics and interactions with exogenous exposures and other known breast cancer risk factors.
Marian C; Ochs-Balcom HM; Nie J; Kallakury BV; Ambrosone CB; Trevisan M; Edge S; Shields PG; Freudenheim JL
Int J Cancer; 2011 Aug; 129(3):702-12. PubMed ID: 20853316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
